Mohsen, M. O., Vogel, M., Riether, C., Muller, J., Salatino, S., Ternette, N., . . . Bachmann, M. F. (2019). Targeting Mutated Plus Germline Epitopes Confers Pre-clinical Efficacy of an Instantly Formulated Cancer Nano-Vaccine. Front Immunol.
シカゴスタイル引用形Mohsen, Mona O., et al. "Targeting Mutated Plus Germline Epitopes Confers Pre-clinical Efficacy of an Instantly Formulated Cancer Nano-Vaccine." Front Immunol 2019.
MLA引用形式Mohsen, Mona O., et al. "Targeting Mutated Plus Germline Epitopes Confers Pre-clinical Efficacy of an Instantly Formulated Cancer Nano-Vaccine." Front Immunol 2019.
警告: この引用は必ずしも正確ではありません.